State Of Wyoming Axsome Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $260 - $561	12 Added 30.0%	52 $2,000
Q1 2022 May 13, 2022	BUY	$23.7 - $41.39 $260 - $455	11 Added 37.93%	40 $2,000
Q4 2021 Feb 11, 2022	SELL	$30.7 - $43.36 $61 - $86	-2 Reduced 6.45%	29 $1,000
Q3 2021 Feb 11, 2022	SELL	$19.91 - $68.26 $438 - $1,501	-22 Reduced 41.51%	31 $1,000
Q2 2021 Feb 11, 2022	BUY	$50.63 - $73.5 $1,113 - $1,617	22 Added 70.97%	53 $4,000
Q1 2021 Feb 08, 2022	BUY	$55.91 - $81.44 $1,733 - $2,524	31 New	31 $2,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.64B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.